|
Market Closed -
Euronext Paris
00:55:00 11/11/2026 HKT
|
Pre-market 14:43:59 | |||
| 29.02 EUR | +1.82% |
|
29.02 | 0.00% |
| 10-26 | Analysts unanimous after Nanobiotix's NBTXR3 results |  |
| 10-26 | Nanobiotix unveils encouraging results in the treatment of advanced melanoma | |
| Market Cap | 1.47B 1.64B 1.36B 1.23B 2.34B 154B 2.4B 16.27B 6.48B 82.59B 6.17B 6.04B 261B | P/E 2026 * |
-46.7x | P/E 2027 * | -116x |
|---|---|---|---|---|---|
| Enterprise Value | 1.49B 1.66B 1.37B 1.25B 2.36B 156B 2.43B 16.45B 6.55B 83.5B 6.24B 6.11B 264B | EV / Sales 2026 * |
50.6x | EV / Sales 2027 * | 34.9x |
| Free-Float |
84.75% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Euronext Paris
| NANO | Real-time | |
CBOE
| NANOp | Real-time | |
|
Börse Stuttgart
| 5NR | Delayed | |
|
Tradegate
| 5NR | Real-time | |
|
London S.E.
| 0QAV | Delayed | |
|
Xetra
| 5NR | Delayed | |
|
Boerse Muenchen
| 5NR | Real-time | |
|
CBOE
| 0QAV | Real-time | |
|
Deutsche Boerse AG
| 5NR | Delayed |
Last Transcript: Nanobiotix
| 1 day | +1.82% | ||
| 1 week | +13.63% | ||
| Current month | +3.20% | ||
| 1 month | +36.63% | ||
| 3 months | -10.71% | ||
| 6 months | -21.36% | ||
| Current year | +48.82% |
| 1 week | 25.8 |  | 29.64 |
| 1 month | 18.46 | | 31.32 |
| Current year | 16.66 | | 47.66 |
| 1 year | 16.52 | | 47.66 |
| 3 years | 2.62 | | 47.66 |
| 5 years | 1.61 | | 47.66 |
| 10 years | 1.61 | | 47.66 |
| Manager | Title | Age | Since |
|---|---|---|---|
Laurent Lévy
CEO | Chief Executive Officer | 55 | 16/11/2009 |
Arnd Christ
DFI | Director of Finance/CFO | 59 | 01/10/2026 |
Louis Kayitalire
CTO | Chief Tech/Sci/R&D Officer | 68 | 05/09/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Alain Herrera
BRD | Director/Board Member | 76 | 23/06/2011 |
| Director/Board Member | 65 | 01/01/2014 | |
Enno Spillner
BRD | Director/Board Member | 57 | 18/06/2014 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 17/7/26 | Buy | Chairman | 598 | 0.0012% | ||
| 17/7/26 | Buy | Chairman | 598 | 0.0012% | ||
| 16/7/26 | Buy | Chairman | 6,114 | 0.0121% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.82% | +13.63% | +49.90% | +441.42% | 1.64B | |
| +0.01% | +11.10% | +60.83% | +70.43% | 68.32B | |
| +1.22% | +9.56% | +15.97% | +90.23% | 60.26B | |
| +0.24% | +1.35% | +23.78% | +97.55% | 55.86B | |
| +1.60% | +19.44% | +28.80% | +112.95% | 48.43B | |
| -1.32% | +4.78% | +29.15% | +40.40% | 45.34B | |
| -3.54% | -0.60% | +207.76% | +879.50% | 41.76B | |
| -3.33% | +6.90% | +22.78% | +48.07% | 34.5B | |
| -2.19% | -3.71% | +90.94% | +66.33% | 33.8B | |
| -2.38% | +0.37% | +45.91% | -0.61% | 25.96B | |
| Average | -0.78% | +6.59% | +57.58% | +184.62% | 42B | |
| Weighted average by Cap. | -0.69% | +5.79% | +55.24% | +154.70% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 29.44M 32.83M 27.13M 24.64M 46.64M 3.08B 47.94M 325M 129M 1.65B 123M 121M 5.21B | 44.36M 49.47M 40.89M 37.13M 70.27M 4.64B 72.24M 490M 195M 2.49B 186M 182M 7.86B |
| Net income | -28.75M -32.06M -26.5M -24.07M -45.55M -3.01B -46.82M -317M -126M -1.61B -120M -118M -5.09B | 604K 673K 556K 505K 956K 63.12M 983K 6.66M 2.65M 33.82M 2.53M 2.47M 107M |
| Net Debt | 16.09M 17.94M 14.83M 13.47M 25.49M 1.68B 26.2M 178M 70.73M 901M 67.33M 65.9M 2.85B | 74.7M 83.29M 68.84M 62.52M 118M 7.81B 122M 824M 328M 4.18B 313M 306M 13.23B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/11/26 | €29.02 | +1.82% | 91,916 |
| 09/11/26 | €28.50 | +5.56% | 108,403 |
| 06/11/26 | €27.00 | -1.03% | 107,831 |
| 05/11/26 | €27.28 | +1.49% | 164,900 |
| 04/11/26 | €26.88 | +5.25% | 153,009 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- NANO Stock
Select your edition
All financial news and data tailored to specific country editions
